Tissue Transglutaminase Test Market Size Is Expected to Exhibit 17.5% By 2023

0

Tissue Transglutamin

iCrowdNewswire   Jan 26, 2021  2:10 AM ET

Global Tissue Transglutaminase Test Market Competitive Landscape

The global tissue transglutaminase test market is observed to be growing upwards due to the technological advancements of key players like Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, and Bio-Rad Laboratories, Inc., Pfizer Inc., Amgen Inc., Ajinomoto Co, Inc., Yiming Biological Products Co., Ltd., Micro-Tech Foods Ingredients, Inc, Kinry Food Ingredients Co., Ltd., Nanning Pangbo Biological Engineering Co., Ltd., and BioRap Technologies Ltd.

The well-established market players are involved in strategic collaborations and new product launches to gain an edge over other competitors in this market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/824

Some of the key players in this market are Quest Diagnostics Incorporated., SQI Diagnostics, Trinity Biotech, Zedira GmbH, Demeditec Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, and Bio-Rad Laboratories, Inc., Pfizer Inc., Amgen Inc., Ajinomoto Co, Inc., Yiming Biological Products Co., Ltd., Micro-Tech Foods Ingredients, Inc, Kinry Food Ingredients Co., Ltd., Nanning Pangbo Biological Engineering Co., Ltd. and BioRap Technologies Ltd.

Tissue Transglutaminase Test Market Scenario

Tissue transglutaminase (TG) test is used for the diagnosis of certain autoimmune diseases, which is mostly limited to celiac disease. In celiac disease, gluten (a protein found in wheat, barley, rye, and oats) is seen as a foreign invader and is attacked by the immune system, followed by the production of antibodies directed against the enzyme Tissue Transglutaminase (TG) (a calcium dependent proteolysis restricting enzyme), which is normally present in intestines.

Immunoglobulin A (IgA) and immunoglobulin G (IgG) are the antibodies responsible for the autoimmune responses. The IgA form of TG antibody is more frequently exploited for the diagnosis of celiac disease. This is because it is synthesized in the small intestine where gluten causes inflammation and irritation in sensitive people. Its application in testing is marked when patient is incapable to produce normal IgA as it is less specific to celiac disease.

The market is expected to grow at a CAGR of ~17.5% during the forecast period of 2018 to 2023. The major factor that propels the global tissue transglutaminase test market is the increasing prevalence of celiac disease and an increasing geriatric population. False positive diagnosis in geriatric population restrain the growth of the market.

Tissue Transglutaminase Test Market Regional Analysis

The tissue transglutaminase test market is segmented into the Americas, Europe, Asia-Pacific and Middle East & Africa.

The Americas account for a significant market share owing to high usage of medications and high expenditure on the health care facilities and products. Moreover, the fast uptake of new technological advancements in the United States drive the global tissue transglutaminase test market. Additionally, the concentration of major research companies and research organizations in the developed countries of this region boost the market growth.

Europe is the second largest market in the world. This is because of high income and healthcare penetration in the region.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/tissue-transglutaminase-test-market-824

Asia Pacific region is expected to grow speedily. Some of the countries in this region, namely India and China are expected to lead this market due to fast growing healthcare sector during the forecast period.

Gulf nations such as Saudi Arabia and the UAE are projected to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and poor healthcare development. Also, difficult political conditions may hinder the growth.

Browse More Related Reports at:

Cold Pain Therapy Market Research Report – Forecast to 2023 | MRFR

Chronic Lymphocytic Leukemia Treatment Market Size and Share | Forecast to 2023

Global Coronary Stents Market Demand, Size, Share, Growth, Forecast to 2023 | MRFR

Controlled Release Drug Delivery Market Share, Trends, Size and Industry Forecast to 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact Information:

Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]


iCrowdNewswire

Keywords:    Tissue Transglutaminase Test Market Size, Tissue Transglutaminase Test Market Trends, Tissue Transglutaminase Test Market Growth, Tissue Transglutaminase Test Market Share, Tissue Transglutaminase Test Market Insights, Tissue Transglutaminase Test Market Growth, Tissue Transglutaminase Test Market Dynamics, Tissue Transglutaminase Test Industry, Tissue Transglutaminase Test Market Key Players

LEAVE A REPLY

Please enter your comment!
Please enter your name here